ZBIO Zenas BioPharma, Inc.
Fundamentals / CIK 0001953926 / USDZenas BioPharma, Inc. reported $10.00M in revenue and a net loss of $541.8M for the fiscal year ended December 31, 2025 (up 100.0% year over year), with a -5264.0% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ZBIO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$10.00M +100.0% YoY
-
Operating Income FY 2025-$526.4M -5264.0% margin
-
Net Income FY 2025-$541.8M -5418.1% net margin
-
Diluted EPS FY 2025-$8.19 Split-adjusted
-
Free Cash Flow FY 2025-$242.8M -2428.3% FCF margin
-
Cash & ST Investments Sep 30, 2026$585.3M Total debt: $1.54M
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Revenue | $10.00M | $5.00M | $50.00M |
| Research & Development | $168.1M | $139.1M | $60.03M |
| Total Operating Expenses | $393.1M | $168.9M | $87.15M |
| Operating Income | -$383.1M | -$163.9M | -$37.15M |
| EBITDA | -$383.0M | -$163.8M | -$37.03M |
| Interest Income | $12.15M | $7.97M | -- |
| Interest Expense | $7.33M | -- | -- |
| Income Before Tax | -$377.8M | -$156.6M | -$36.82M |
| Income Tax Expense | -$79K | $429K | $301K |
| Net Income | -$377.7M | -$157.0M | -$37.12M |
| Basic EPS | -$8.44 | -$11.89 | -$24.25 |
| Diluted EPS | -$8.44 | -$11.89 | -$24.25 |
| Basic Shares Outstanding | 44.7M | 13.2M | 1.5M |
| Diluted Shares Outstanding | 44.7M | 13.2M | 1.5M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.00M | $1.00M | -- | $0 | $0 | $0 | $10.00M | -- |
| Research & Development | $58.47M | $62.91M | $60.44M | $55.72M | $34.40M | $43.03M | $34.91M | $49.16M |
| Total Operating Expenses | $113.4M | $108.7M | $77.35M | $238.0M | $52.58M | $55.16M | $47.33M | $60.62M |
| Operating Income | -$103.4M | -$107.7M | -$77.35M | -$238.0M | -$52.58M | -$55.16M | -$37.33M | -$55.62M |
| EBITDA | -$103.4M | -$107.7M | -$77.34M | -$238.0M | -$52.57M | -$55.15M | -$37.31M | -$55.59M |
| Interest Income | $5.79M | $6.60M | $3.02M | $3.25M | $2.77M | $2.74M | $3.39M | -- |
| Interest Expense | $2.06M | $1.72M | $368K | -- | -- | -- | -- | -- |
| Income Before Tax | -$108.9M | -$111.3M | -$80.99M | -$240.3M | -$51.50M | -$52.20M | -$33.78M | -$52.17M |
| Income Tax Expense | $49K | $114K | -- | $106K | $0 | $20K | -$205K | -- |
| Net Income | -$108.9M | -$111.5M | -$80.99M | -$240.4M | -$51.50M | -$52.22M | -$33.57M | -$52.60M |
| Basic EPS | -$1.65 | -$1.77 | -$1.46 | -- | -$1.22 | -$1.25 | -$0.80 | -- |
| Diluted EPS | -$1.65 | -$1.77 | -$1.46 | -- | -$1.22 | -$1.25 | -$0.80 | -- |
| Basic Shares Outstanding | 66.1M | 63.1M | 55.6M | -- | 42.2M | 41.9M | 41.8M | -- |
| Diluted Shares Outstanding | 66.1M | 63.1M | 55.6M | -- | 42.2M | 41.9M | 41.8M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & Cash Equivalents | $110.6M | $319.7M | $56.86M |
| Short-Term Investments | $232.6M | $31.02M | -- |
| Cash & Short-Term Investments | $360.5M | $350.8M | $56.86M |
| Total Current Assets | $351.2M | $355.9M | $59.80M |
| Property, Plant & Equipment, Net | $34K | $185K | $193K |
| Long-Term Investments | $17.27M | -- | -- |
| Other Non-Current Assets | $13.81M | $12.86M | $7.28M |
| Total Non-Current Assets | $32.47M | $14.04M | $8.38M |
| Total Assets | $383.6M | $370.0M | $68.18M |
| Accounts Payable | $7.11M | $17.14M | $5.40M |
| Total Current Liabilities | $62.65M | $57.29M | $23.26M |
| Long-Term Debt | $78.64M | -- | -- |
| Total Non-Current Liabilities | $78.85M | $218K | $20.56M |
| Total Liabilities | $141.5M | $57.51M | $43.81M |
| Total Debt (incl. Leases) | $79.96M | $1.00M | $813K |
| Common Stock | $5.0K | $4.0K | -- |
| Retained Earnings | -$765.1M | -$387.4M | -$230.4M |
| Accumulated Other Comp. Income | -$64K | $194K | $37K |
| Total Stockholders' Equity | $242.1M | $312.5M | -$225.7M |
| Total Equity | $242.1M | $312.5M | -$225.7M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $177.8M | $196.6M | $500.2M | $110.6M | $115.6M | $44.01M | $196.6M | $319.7M |
| Short-Term Investments | $407.5M | $446.5M | $217.0M | $232.6M | $175.3M | $229.3M | $115.8M | $31.02M |
| Cash & Short-Term Investments | $647.1M | $673.9M | $718.5M | $360.5M | $301.6M | $274.9M | $314.2M | $350.8M |
| Total Current Assets | $603.4M | $653.8M | $730.2M | $351.2M | $296.6M | $278.6M | $317.8M | $355.9M |
| Property, Plant & Equipment, Net | $19K | $23K | $28K | $34K | $50K | $61K | $72K | $185K |
| Long-Term Investments | $61.77M | $30.76M | $1.34M | $17.27M | $10.72M | $1.61M | $1.83M | -- |
| Other Non-Current Assets | $8.39M | $16.29M | $15.06M | $13.81M | $13.80M | $11.80M | $12.85M | $12.86M |
| Total Non-Current Assets | $71.77M | $47.90M | $17.52M | $32.47M | $25.38M | $14.48M | $15.96M | $14.04M |
| Total Assets | $675.2M | $701.7M | $747.7M | $383.6M | $322.0M | $293.1M | $333.8M | $370.0M |
| Accounts Payable | $7.06M | $7.59M | $8.94M | $7.11M | $6.44M | $7.93M | $20.02M | $17.14M |
| Deferred Revenue (Current) | $2.03M | -- | -- | -- | -- | -- | -- | -- |
| Total Current Liabilities | $64.04M | $65.82M | $61.16M | $62.65M | $52.42M | $53.24M | $49.13M | $57.29M |
| Long-Term Debt | -- | -- | -- | $78.64M | $72.99M | -- | -- | -- |
| Total Non-Current Liabilities | $398.9M | $388.8M | $350.7M | $78.85M | $73.17M | $215K | $317K | $218K |
| Total Liabilities | $462.9M | $454.6M | $411.9M | $141.5M | $125.6M | $53.46M | $49.45M | $57.51M |
| Total Debt (incl. Leases) | $1.54M | $845K | $1.11M | $79.96M | $73.79M | $1.01M | $1.23M | $1.00M |
| Common Stock | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K |
| Retained Earnings | -$1.07B | -$957.6M | -$846.1M | -$765.1M | -$524.7M | -$473.2M | -$421.0M | -$387.4M |
| Accumulated Other Comp. Income | -$1.26M | -$1.14M | -$377K | -$64K | -$69K | -$94K | $141K | $194K |
| Total Stockholders' Equity | $212.3M | $247.1M | $335.8M | $242.1M | $196.4M | $239.6M | $284.3M | $312.5M |
| Total Equity | $212.3M | $247.1M | $335.8M | $242.1M | $196.4M | $239.6M | $284.3M | $312.5M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | -$377.7M | -$157.0M | -$37.12M |
| Depreciation & Amortization | $56K | $137K | $113K |
| Stock-Based Compensation | $26.35M | $10.82M | $3.50M |
| Change in Payables | -$10.04M | $11.74M | -$418K |
| Operating Cash Flow | -$172.3M | -$119.7M | -$30.53M |
| Capital Expenditure | -$18K | -$131K | -$17K |
| Free Cash Flow | -$172.4M | -$119.8M | -$30.55M |
| Purchases of Investments | -$417.8M | -$36.42M | -- |
| Sales & Maturities of Investments | $200.9M | $6.00M | -- |
| Investing Cash Flow | -$251.9M | -$30.55M | -$17K |
| Financing Cash Flow | $215.3M | $413.0M | $20.12M |
| Net Change in Cash | -$209.2M | $262.9M | -$10.35M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$108.9M | -$111.5M | -$80.99M | -$240.4M | -$51.50M | -$52.22M | -$33.57M | -$52.60M |
| Depreciation & Amortization | $4.0K | $4.0K | $6.0K | $10K | $11K | $12K | $23K | $33K |
| Stock-Based Compensation | $17.28M | $8.62M | $9.20M | $7.58M | $7.34M | $6.04M | $5.39M | $5.50M |
| Change in Payables | -$514K | -$1.33M | $1.79M | $1.12M | -$1.95M | -$12.09M | $2.88M | $5.42M |
| Operating Cash Flow | -$57.98M | -$57.24M | -$75.20M | -$52.41M | -$41.12M | -$41.74M | -$37.05M | -$38.55M |
| Capital Expenditure | -$1.0K | $0 | -$2.0K | $0 | $0 | $0 | -$18K | -$74K |
| Free Cash Flow | -$57.98M | -$57.24M | -$75.20M | -$52.41M | -$41.12M | -$41.74M | -$37.07M | -$38.63M |
| Purchases of Investments | -$137.5M | -$331.8M | -$76.52M | -$132.9M | -$59.20M | -$126.6M | -$99.11M | -- |
| Sales & Maturities of Investments | $145.8M | $74.11M | $108.1M | $69.53M | $104.2M | $14.26M | $12.86M | -- |
| Investing Cash Flow | -$19.21M | -$287.7M | $31.61M | -$93.36M | $40.04M | -$112.3M | -$86.27M | -$3.73M |
| Financing Cash Flow | $57.21M | $42.06M | $433.5M | $140.8M | $72.62M | $1.72M | $99K | $1.85M |
| Net Change in Cash | -$18.80M | -$303.6M | $389.6M | -$4.92M | $71.56M | -$152.5M | -$123.3M | -$40.30M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Operating Margin | -3830.6% | -3277.8% | -74.3% |
| Net Profit Margin | -3777.4% | -3139.8% | -74.2% |
| Return on Equity (ROE) | -156.0% | -50.2% | -- |
| Return on Assets (ROA) | -98.5% | -42.4% | -54.4% |
| Current Ratio | 5.61x | 6.21x | 2.57x |
| Quick Ratio | 5.75x | 6.12x | 2.44x |
| Debt to Equity | 0.33x | 0.00x | -- |
| Revenue Growth (YoY) | +100.0% | -90.0% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -- | -3830.6% | -- | -- | -- | -- |
| Net Profit Margin | -- | -- | -- | -3777.4% | -- | -- | -- | -- |
| Return on Equity (ROE) | -255.2% | -196.0% | -126.6% | -156.0% | -96.7% | -73.9% | -57.2% | -50.2% |
| Return on Assets (ROA) | -80.2% | -69.0% | -56.9% | -98.5% | -59.0% | -60.4% | -48.8% | -42.4% |
| Current Ratio | 9.42x | 9.93x | 11.94x | 5.61x | 5.66x | 5.23x | 6.47x | 6.21x |
| Quick Ratio | 10.10x | 10.24x | 11.75x | 5.75x | 5.75x | 5.16x | 6.40x | 6.12x |
| Debt to Equity | 0.01x | 0.00x | 0.00x | 0.33x | 0.38x | 0.00x | 0.00x | 0.00x |